Higher pyruvate levels after Achilles tendon rupture surgery could be used as a prognostic biomarker of an improved patient outcome
Autor: | Paul W. Ackermann, Simon Svedman, Gunnar Edman, Gianluigi Capone, Robin Juthberg |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male Pyruvate medicine.medical_specialty Healing Metabolite Operative Time Achilles Tendon Time-to-Treatment 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Pyruvic Acid medicine Humans Orthopedics and Sports Medicine Prognostic biomarker Lactic Acid Patient Reported Outcome Measures Exercise Early Ambulation Rupture Wound Healing 030222 orthopedics Achilles tendon business.industry Biomarker 030229 sport sciences Middle Aged Early mobilization Tendon Surgery Treatment Outcome medicine.anatomical_structure chemistry Patient-reported outcome measures Pedometer Orthopedic surgery Lactate Biomarker (medicine) Female Ankle Achilles tendon rupture medicine.symptom business Biomarkers |
Zdroj: | Knee Surgery, Sports Traumatology, Arthroscopy |
ISSN: | 1433-7347 0942-2056 |
DOI: | 10.1007/s00167-020-06037-x |
Popis: | Purpose The primary aim of this study was to assess the relationship between the metabolites lactate and pyruvate in the healing tendon after Achilles tendon rupture (ATR) and patient-reported outcome at 6 and 12 months. A secondary aim was to evaluate which underlying factors regulate lactate and pyruvate concentrations. Methods Lactate and pyruvate concentrations were measured two weeks post-operatively in both the healing- and healthy Achilles tendon in 109 patients (90 men, 19 women; mean age 40 ± 7.9 years). Patient demographics, degree of physical activity, timing of surgery, operation time, patient-reported loading and step counts were investigated in relation to metabolite concentrations. At 6 and 12 months, the Achilles tendon Total Rupture Score (ATRS) questionnaire was used to assess patient outcome. Results The mean number of steps taken during the post-operative days 1–10 was the only factor significantly related to the mean concentration of lactate (R2 = 0.34, p = 0.038), and pyruvate (R2 = 0.46, p = 0.006). Pyruvate was demonstrated as the only factor significantly associated with ATRS at both 6 months (R2 = 0.32, p = 0.003) and at 12 months (R2 = 0.37, p = 0.004) using multiple linear regression. Conclusion The mean concentration of pyruvate during early ATR healing may predict patient outcome at 6 and 12 months post-operatively and possibly be used as a biomarker of healing. Early mobilization with an increased number of steps taken is an important clinical strategy to improve the metabolite concentrations during healing. Level of evidence III |
Databáze: | OpenAIRE |
Externí odkaz: |